Form 4 for VNRX VOLITIONRX LTD
Accepted 2022-04-08 00:00:00 ET · period of report 2022-04-07 · accession 0001477932-22-002175 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-08 | 2022-04-07 | VNRX | Gaetan Michel | COO | A - Grant | $0.00 | +13.9K | 15.0K | +1,301% | $0 |
| D | 2022-04-08 | 2022-04-07 | VNRX | Gaetan Michel | COO | A - Grant | $0.00 | +25.7K | 25.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-07 | A | A | 13,933 | $0.00 | 15,004 | D | — | — | (F1) On October 4, 2021, the reporting person was awarded 39,809 restricted stock units, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 13,933 restricted stock units vesting. The restricted stock units are further subject to a 2-year time-based vesting schedule, vesting in two installments of 6,966 units and 6,967 units on each of October 4, 2022 and October 4, 2023, respectively. Upon vesting and settlement, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-04-07 | A | A | 25,676 | $0.00 | 25,676 | D | $3.40 · — to 2031-10-04 | 25,676 Common Stock | (F2) On October 4, 2021, the reporting person was granted an option to purchase 73,360 shares of common stock, subject to vesting upon achievement of certain corporate performance goals on or prior to July 1, 2022 and also subject to time-based vesting. Certain of the performance goals were met, resulting in the rights with respect to 25,676 shares vesting. The vested shares are further subject to a 2-year time based vesting schedule, vesting in two equal installments of 12,838 shares on each of October 4, 2022 and October 4, 2023, respectively. |